← Leaderboards
Paul J Strasma
Capillary Biomedical, Inc.
$2,018,977
Attributed
$2,018,977
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.8M · FY2016–18$2M$1.5M$1M$500K$0
'16
'17
'18
Funding mix
By agency
NIH$2,018,977 · 2
By mechanism
R44$1,750,000 · 1
R43$268,977 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Immune Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,695,345
- Barton F Haynes · Duke University$456,664,915
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$309,708,725
- Peter B. Gilbert · Fred Hutchinson Cancer Center$192,329,665
Research focus
Immune ResponseInsulin, Lispro, HumanDiabetes MellitusGlucose MonitorInsulinInsulin Infusion SystemsDesignDevicesFailureGlucose ClampInfusion PumpsBlood GlucoseBlood Glucose RegulationInsulin-Dependent Diabetes MellitusBolus InfusionAdoptionCannulasArtificial PancreasCathetersDoseBlood CapillariesFundingInfusion ProceduresIn Vitro
Grant awards (3)
Relative Bioavailability of Subcutaneous Insulin over Extended Durations of Infusion Set Use$1,750,000
R44 · FY2018 · DK · contact PI
Multi-Orifice Continuous Subcutaneous Insulin Infusion Catheter with Reduced Pharmacokinetic Variability and Rapid On-Off Pharmacodynamic Actions$45,081
R43 · FY2017 · DK · contact PI
Multi-Orifice Continuous Subcutaneous Insulin Infusion Catheter with Reduced Pharmacokinetic Variability and Rapid On-Off Pharmacodynamic Actions$223,896
R43 · FY2016 · DK · contact PI